High levels of leptin have been associated with an increased risk of breast cancer as well as with a worse prognosis [53]; however, low levels of ghrelin are associated with increased expression of aromatase in adipose tissue and thus with an increased risk of breast cancer [54]. This evidence concerns the gene CYP19A1 and breast carcinoma.